SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001493152-19-014614
Filing Date
2019-09-26
Accepted
2019-09-26 16:24:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 formscto-1a.htm SC TO-I/A 57866
2 exa1c.htm EX-99.(A)(1)(C) 9519
  Complete submission text file 0001493152-19-014614.txt   69570
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filed by) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Subject) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-36676 | Film No.: 191118139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences